{"id":"W2996500186","doi":"10.1002/ejhf.1673","title":"European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose-Lowering Drugs in Patients with Heart Failure","year":2019,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"ca_institutions":"Surgical Specialties (Canada)","funders":"Relypsa; Pfizer; Servier; Boston Scientific Corporation; Sanofi; AstraZeneca","keywords":"Dapagliflozin; Empagliflozin; Medicine; Heart failure; Saxagliptin; Canagliflozin; Ejection fraction; Internal medicine; Cardiology; Liraglutide; Type 2 diabetes; Benzhydryl compounds; Diabetes mellitus; Intensive care medicine; Sitagliptin; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01159806,0.001481013,0.002099337,0.001359582,0.00139457,0.006622544,0.002795512,0.01835757,0.01805943],"category_scores_gemma":[0.02044461,0.0005615363,0.00133808,0.001247282,0.001360025,0.002859786,0.001826111,0.01343481,0.0124768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003002144,"about_ca_system_score_gemma":0.00859132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003332598,"about_ca_topic_score_gemma":0.004580221,"domain_scores_codex":[0.9936207,0.001368857,0.0007589335,0.0008139607,0.002729061,0.0007085327],"domain_scores_gemma":[0.9728091,0.005862577,0.003263494,0.0007725543,0.009312898,0.007979412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002492052,0.00008334458,0.0006197151,0.0005542596,0.0000791061,0.0001250979,0.00003334033,0.00009430939,0.0001968503,0.002360424,0.9080501,0.08755434],"study_design_scores_gemma":[0.0005523785,0.0002262757,0.005065353,0.002403413,0.0001334009,0.000229761,0.00004363286,0.0002776772,0.0002543336,0.003386889,0.9873891,0.00003770549],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.001421599,0.1135414,0.0009487135,0.48841,0.3330573,0.0002359223,0.001677569,0.0001658341,0.06054172],"genre_scores_gemma":[0.0259029,0.1401602,0.003736539,0.2139748,0.5081325,0.0006498198,0.003324069,0.0002932925,0.103826],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01835757,"threshold_uncertainty_score":0.06133717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003845443169605257,"score_gpt":0.186350849677464,"score_spread":0.1825054065078587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}